-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
February 01, 2010 - patient data on a set of core clinical variables consisting of demographics (age, sex,
and ethnicity), cardiac … The
synergy between percutaneous coronary
intervention with taxus and cardiac surgery
(SYNTAX) study … The
SYNergy between percutaneous coronary
intervention with TAXus and cardiac
surgery (SYNTAX) study
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s81.pdf
October 01, 2007 - LOS) was �4 days and there was a
complication; or if LOS was �4 days and the patient was a
woman with cardiac … P-222) 0.21 7 28 94 0.61 7.1 5.32 0.0000
Length of stay �4 d† 0.21 69 90 31 0.60 2.2 3.83 0.0167
Cardiac … Cardiac dysrhythmias and lipid disor-
ders—the latter being a surrogate for coronary artery dis-
ease—are
-
effectivehealthcare-admin.ahrq.gov/products/peripheral-nerve-blocks/protocol
May 01, 2024 - hospital stays, patient anxiety and dissatisfaction, adverse endocrine and neurovascular responses, cardiac … This comparative review will synthesize evidence of PNB effects in intrathoracic surgery, including cardiac … open or minimally invasive (laparoscopic/thoracoscopic), elective, or urgent intrathoracic surgeries*: Cardiac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
December 01, 2010 - diabetic ketoacidosis, neuroleptic malignant syndrome,
seizures, tardive dyskinesia, cardiomyopathies and cardiac … ketoacidosis, neuroleptic
malignant syndrome, seizures, tardive
dyskinesia, cardiomyopathies and cardiac … diabetic ketoacidosis, neuroleptic malignant
syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … agranulocytosis
2. seizures
3. myocarditis
4. cardiovascular and respiratory effects,
(respiratory and/or cardiac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
February 01, 2013 - Associate Chief
Division of Cardiothoracic Surgery
Emory University School of Medicine
Chief of Cardiac … clinical evaluation
of women with suspected coronary artery
disease: consensus statement from the
Cardiac … “heart”[MeSH Terms] OR “heart”[All
Fields] OR “coronary”[All Fields]) OR cardiovas*[All fields] OR cardiac … angina’:ab OR ‘cardiovascular diseases’:ti OR ‘heart diseases’:ti OR heart:ti OR cardiovasc*:ti OR
cardiac … June 5, 2012
Set # Terms
#1 cardiovascular diseases OR heart diseases OR heart OR cardiovas* OR cardiac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
July 01, 2014 - Child
Harm Outcomes
• Death, including suicide, all-cause mortality, and
cause-specific death (e.g., cardiac … No
comparative evidence on the risk of cardiac malformations
in women treated for depression during … Results were
similar for cardiac malformations, except that limiting
our analyses to the highest quality … significantly associated with increased risk for
major malformations (OR, 1.31; 95% CI, 1.04 to 1.65) and
cardiac … First trimester
paroxetine use and the prevalence of congenital, specifically
cardiac, defects: a meta-analysis
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
December 20, 2011 - could be used for diagnosis in acute and non-acute settings, its
prognostic value for HF and other cardiac … was consistent evidence that BNP and NT-proBNP were
independent predictors of mortality and other cardiac … 2005
4,14
have evaluated the evidence that BNP
and NT-proBNP are predictive of mortality and other cardiac … How well does B-type natriuretic peptide predict
death and cardiac events in patients with heart failure
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
February 01, 2012 - affecting outcomes
in their infants, including prevention of neurological
impairment, microcephaly, and cardiac … affecting outcomes in their infants, including prevention
of neurological impairment, microcephaly, and cardiac … measures of
executive
function
• Prevention of
neurologic
impairment
• Prevention of
cardiac … These include studies
on the cardiac effects of BH4.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
July 09, 2024 - has also been given to other
common co-occurring conditions such as hip dysplasia, early menopause, cardiac … syndrome" or "trisomy 21").mp.
2 atherosclerosis/ or cardiac output, high/ or cardiac output, low/
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
February 05, 2025 - has also been given to other
common co-occurring conditions such as hip dysplasia, early menopause, cardiac … syndrome" or "trisomy 21").mp.
2 atherosclerosis/ or cardiac output, high/ or cardiac output, low/
-
effectivehealthcare-admin.ahrq.gov/products/care-adults-down-syndrome/protocol
February 01, 2025 - has also been given to other common co-occurring conditions such as hip dysplasia, early menopause, cardiac … syndrome" or "trisomy 21").mp. 2 atherosclerosis/ or cardiac output, high/ or cardiac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
June 01, 2013 - dissuade a physician from
prescribing it for prophylaxis in patients with COPD include hearing loss and cardiac … dissuade a physician from prescribing it for
prophylaxis in COPD patients include hearing loss and cardiac … Some experts
stated risk of hearing loss, cardiac arrhythmias, and antibiotic resistance are factors
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
October 06, 2006 - Vol-
Death*
Dr Vol-
CABG* Notes
Primary Studies: National
Kimmel S et
al.248
Society for Cardiac … Clinical Databases: National
Peterson E et
al.210
Society of Thoracic Surgeons
National Cardiac … Pts=patients; Hosp=hospital; vol=volume; Dr=physician; RA= Risk adjusted; AE= Adverse events; CSRS=cardiac … Clinical Databases CABG: National
Peterson E et
al.210
Society of Thoracic
Surgeons National
Cardiac … ischemia
ο Other (Specify _______)
Components of Primary Endpoint (N= ) ο Total Mortality
ο Cardiac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
March 10, 2010 - Results Pg 20, line 52- Why didn’t you think it reasonable to pool
cardiovascular mortality and cardiac … which included death from vascular
causes such as stroke) was an inherently different endpoint than cardiac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
March 17, 2020 - obesity, diabetes prevention, hypertension, sleep apnea, coronary artery disease,
heart failure, cardiac … ti OR thrombos*:ti OR calcif*:ti))
21 Heart Failure 'heart failure'/exp OR (((heart OR cardio* OR cardiac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
March 01, 2009 - Collection
Baseline Data
Baseline demographic, medical history, physical examination and initial cardiac … contemporary patients receiving percutaneous coronary
intervention, the long-term risk for death and major cardiac … Acknowledgments
We acknowledge the commitment of faculty and staff of the cardiac
catheterization
-
effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children/research-protocol
December 01, 2019 - ketoacidosis
Neuroleptic malignant syndrome
Seizures
Tardive dyskinesia
Cardiomyopathies
Cardiac … diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … 2. seizures
3. myocarditis
4. cardiovascular and respiratory effects, (respiratory and/or cardiac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
October 08, 2014 - o include GFR threshold and how measured
§ New onset diabetes after transplant
§ Major adverse cardiac … an d timing var iation s
KQ3
Adverse events:
• Nephrotoxicity
• New onset diabetes
• Major cardiac … living (related or non-related) or
deceased donor renal transplant (brain dead donors, donors after cardiac … type (living donor or deceased donor; for deceased donors: expanded criteria donors,
donation after cardiac
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
March 29, 2011 - affecting
outcomes in their infants, including prevention of neurological impairment,
microcephaly, and cardiac … affecting outcomes in their
infants, including prevention of neurological impairment, microcephaly, and cardiac … Prevention of cardiac defects
3. Normal growth
4. … Prevention of cardiac defects
3. Normal growth
4.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
January 01, 2024 - app-based clinical decision support for atrial fibrillation management.20,23-25
Remote monitoring of cardiac … or software) for
anticoagulation
monitoring
Moderate
CCT = controlled clinical trial; CRT-D = cardiac … resynchronization therapy defibrillator; ICD = implantable cardiac defibrillator;
PM = pacemaker; PSP … 0.80)
AF = atrial fibrillation; CCT = controlled clinical trial; CI = confidence interval; CRT-D = cardiac … resynchronization therapy defibrillator; HR = hazard ratio; ICD = implantable
cardiac defibrillator